Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

MBX Biosciences, Inc. MBX

Set alert

Price alert · MBX

All alert types
55.87 USD +1.33 +2.44%

At close · Oct 30

56.50 +0.63 +1.13%

After hours · Oct 30, 4:15 PM ET

Bid
55.71 × 2
Ask
55.82 × 2
52.29 Day range 56.52
20.61 52-week range 70.70
YTD
+77.14%
1 year
+156.40%
Open
53.72
Prev close
54.54
Mkt cap
2.69B
Vol
667.27K
Avg vol
510.80K
EPS
-2.37
P/E
0.00
Div yield
0.00%
More statistics
Low
52.29
High
56.52
Forward P/E
-14.01
Beta
0.10
Short ratio
6.96
Inst. own
116.03%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
58.03
200-d avg
45.52
1y target
95.70

5D chart

Chart tools
Interval
1m5m15m30m
MBX five-day price chart47.950.052.154.156.2Oct 26Oct 27Oct 28Oct 29

Financial health

Altman Z-Score

60.60 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 1

Valuation

P/E -13.3×
FY 2022: -28.8×FY 2023: -23.2×FY 2024: -10.0×FY 2025: -13.3×
FY 2022 5y median -18.2× FY 2025
P/S 0.0×
FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2022 5y median 0.0× FY 2025
P/B 3.1×
FY 2022: -17.7×FY 2023: -10.4×FY 2024: 2.4×FY 2025: 3.1×
FY 2022 5y median -4.0× FY 2025
P/FCF -14.1×
FY 2022: -32.0×FY 2023: -23.5×FY 2024: -11.1×FY 2025: -14.1×
FY 2022 5y median -18.8× FY 2025
EV/EBITDA -12.4×
FY 2022: -28.4×FY 2023: -22.3×FY 2024: -9.2×FY 2025: -12.4×
FY 2022 5y median -17.4× FY 2025
EV/Sales 0.0×
FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2022 5y median 0.0× FY 2025
FCF Yield -7.1%
FY 2022: -3.1%FY 2023: -4.3%FY 2024: -9.0%FY 2025: -7.1%
FY 2022 5y median -5.7% FY 2025

Profitability

Gross Margin 0.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2022 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2022 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2022 5y median 0.0% FY 2025
ROE -23.6%
FY 2022: 61.3%FY 2023: 44.9%FY 2024: -24.1%FY 2025: -23.6%
FY 2022 5y median 10.7% FY 2025
ROIC -26.5%
FY 2022: -60.2%FY 2023: -43.9%FY 2024: -26.5%FY 2025: -26.5%
FY 2022 5y median -35.2% FY 2025
ROA -22.6%
FY 2022: -58.0%FY 2023: -38.7%FY 2024: -23.1%FY 2025: -22.6%
FY 2022 5y median -30.9% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2022 FY 2025
Operating Income -43.8%
FY 2022: 0.0%FY 2023: -40.3%FY 2024: -93.1%FY 2025: -43.8%
FY 2022 FY 2025
EPS (diluted) -28.6%
FY 2022: 0.0%FY 2023: -24.4%FY 2024: -81.4%FY 2025: -28.6%
FY 2022 FY 2025
Free Cash Flow -47.4%
FY 2022: 0.0%FY 2023: -36.3%FY 2024: -73.0%FY 2025: -47.4%
FY 2022 FY 2025

Financial Health

Current Ratio 24.6×
FY 2022: 12.9×FY 2023: 21.3×FY 2024: 24.2×FY 2025: 24.6×
FY 2022 5y median 22.7× FY 2025
Quick Ratio 24.6×
FY 2022: 12.9×FY 2023: 21.3×FY 2024: 24.2×FY 2025: 24.6×
FY 2022 5y median 22.7× FY 2025
Debt / Equity 0.0×
FY 2022: -0.0×FY 2023: -0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2022 5y median -0.0× FY 2025
Net Debt / EBITDA 0.9×
FY 2022: 0.9×FY 2023: 0.9×FY 2024: 0.8×FY 2025: 0.9×
FY 2022 5y median 0.9× FY 2025
Interest Coverage 0.0×
FY 2022: -67.3×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2022 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2022 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2022 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31